Skip to content
OpenCapital
Get started

Mesa Laboratories MLAB Q2 2026 earnings

Reported November 6, 2025 · After market close

Revenue$60.7MMiss by $296.3KDiluted EPS$1.76Beat by $0.20
Revenue estimate$61.0M
EPS estimate$1.56

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$60.9M
EPS estimate$2.63

Financials

Q2 2026

Income statement

See full
Revenue$60.7M+5.0%
Net income$2.5M-27.8%

Balance sheet

See full
Cash & equivalents$20.4M-16.1%
Total debt$68.0M-59.8%
Total equity$178.5M+10.5%
Total assets$430.4M-5.2%

Cash flow

See full
Operating cash flow$8.2M+56.0%
CapEx$1.1M-38.9%
Free cash flow$7.1M+105%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$368.65M-47.4%
Enterprise value$416.21M-50.8%
P/S1.5×-1.6×

Profitability

See full
Net margin-0.6%-0.3pp
FCF margin15.2%-0.6pp

Returns & leverage

See full
Return on equity-0.9%-0.5pp
Debt / equity0.4×-0.7×
Current ratio2×+1.3×

Segments

By geography

See full
US$29.3M+4.4%
Other$26.1M+16.8%
CN$5.3M-28.1%

By segment

See full
Biopharmaceutical Development$13.9M—
Clinical Genomics$11.1M—

By product

See full
Consumables$33.4M—
Hardware And Software$16.1M—

Versus estimates

Revenue

Q4 2026$63.7MMiss by $1.5MQ3 2026$65.1MBeat by $1.9M
Q2 2026$60.7MMiss by $296.3K
Q1 2026$59.5MMiss by $857.0KQ4 2025$62.1MBeat by $235.0KQ3 2025$62.8MBeat by $1.3M

Diluted EPS

Q4 2026$2.76Beat by $0.67Q3 2026$3.07Beat by $1.67
Q2 2026$1.76Beat by $0.20
Q1 2026$2.32Miss by $0.14Q4 2025$2.23Miss by $0.52Q3 2025$2.67Beat by $1.26

Ask the moment Mesa Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Mesa Laboratories report Q2 2026 earnings?
Mesa Laboratories (MLAB) reported Q2 2026 earnings on November 6, 2025 after market close.
What were Mesa Laboratories's Q2 2026 revenue and EPS?
Mesa Laboratories reported revenue of $60.7M and diluted EPS of $1.76 for Q2 2026.
Did Mesa Laboratories beat estimates in Q2 2026?
Revenue missed the consensus estimate of $61.0M by $296.3K. EPS beat the consensus estimate of $1.56 by $0.20.
How did Mesa Laboratories's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.0% from $57.8M a year earlier and diluted EPS declined 28.2% from $2.45.
Where can I find Mesa Laboratories's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000724004-25-000012) and the 10-Q periodic report (0000724004-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.